Show simple item record

Development of paclitaxel and flurbiprofen coloaded PLGA nanoparticles: understanding critical formulation and process parameters using Plackett– Burman design

dc.contributor.advisor
dc.contributor.advisordc. contributor. author
dc.contributor.authorSahin, Adem
dc.contributor.authorCaban Toktas, Secil
dc.contributor.authorTonbul, Hayrettin
dc.contributor.authorYerlikaya, Firat
dc.contributor.authorAktas, Yesim
dc.contributor.authorCapan, Yildiz
dc.date.accessioned2020-10-26T12:24:23Z
dc.date.available2020-10-26T12:24:23Z
dc.date.issued2019
dc.identifier10.26650/IstanbulJPharm.2019.19036
dc.identifier.issn2548-0731
dc.identifier.urihttp://hdl.handle.net/20.500.12591/313
dc.sourceIstanbul Journal of Pharmacy
dc.titleDevelopment of paclitaxel and flurbiprofen coloaded PLGA nanoparticles: understanding critical formulation and process parameters using Plackett– Burman design


Files in this item

Thumbnail
Name:
Development of paclitaxel and ...
Size:
1.668Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record